Investment Summary

Andera Partners Invests In Exciva

On October 26, 2021, private equity firm Andera Partners invested in life science company Exciva

Investment Highlights
  • This is Andera Partners’ 24th transaction in the Life Science sector.
  • This is Andera Partners’ 4th transaction in Germany.

Investment Summary

Date 2021-10-26
Target Exciva
Sector Life Science
Investor(s) Andera Partners
Deal Type Venture

Target

Exciva

Heidelberg, Germany
Exciva is a clinical biotech company developing a novel therapeutic compound for the treatment of behavioral and psychological symptoms in alzheimer’s patients. Exciva was founded in 2016 and is based in Heidelberg, Germany.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Andera Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.


DEAL STATS #
Overall 92 of 106
Sector: Life Science M&A 24 of 27
Type: Venture M&A Deals 25 of 28
Country: Germany M&A 4 of 5
Year: 2021 M&A 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-16 Amolyt Pharma

Ecully, France

Amolyt Pharma is a clinical-stage biotechnology company, building therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma was founded in 2015 and is based in Ecully, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-08 Immo City

Montreuil, France

Immo City is a real estate company. The group offers its clients co-ownership trustee, rental management and real estate transaction services, mainly for residential properties. Immo City was founded in 1999 and is based in Montreuil, France.

Buy -